Gene Therapy May Be Cure for Rare Blood Disorder – WebMD
WebMD |
Gene Therapy May Be Cure for Rare Blood Disorder
WebMD She wanted to be free to go where she pleased, unshackled by her disorder. Thanks to a revolutionary new genetic therapy, Sihanath hasn’t needed a blood transfusion for four years. She’s now 22 and a senior at Arizona State University studying … Gene Therapy May Be Cure for Some With Rare Blood DisorderHealthDay |
CNN |
Gene therapy helps patients avoid blood transfusion, study says
CNN The study “actually allows us to envision treating thalassemia with curative intent using the patient as their own donor,” she said. “If we can envision treating patients as if the patients were their own donors, they are not exposed to some of the … Beta-Thalassemia Treatment With Gene Therapy Reduced … – NPRNPR Gene therapy could free some people from a lifetime of blood transfusionsMIT Technology Review Thalassaemia gene therapy trial shows ‘encouraging’ resultsBBC News The New Yorker –Wall Street Journal –Endpoints News –The New England Journal of Medicine all 21 news articles » |
Jewish Chronicle |
‘Join stem cell register to help grandma find match for transplant’
Jewish Chronicle Adam Levinson has issued a heartfelt plea for more Jews to join the stem cell register in a bid to boost the search for a transplant match for his mother, Hilary. Leeds-based Mrs Levinson, 62, was diagnosed with acute myeloid leukaemia in September … |
|
Global Synthetic Biology Market: Widening Application Base to Boost Market’s Growth, Says TMR
GlobeNewswire (press release) ALBANY, New York, April 19, 2018 (GLOBE NEWSWIRE) — As per the research report, the global synthetic biology market, which stood at US$1.8 bn in 2012, is anticipated to expand exponentially at a CAGR of 32.60% during the period from 2013 to 2019 and … |
|
Global Synthetic Biology Market: Widening Application Base to Boost Market’s Growth, Says TMR
GlobeNewswire (press release) ALBANY, New York, April 19, 2018 (GLOBE NEWSWIRE) — As per the research report, the global synthetic biology market, which stood at US$1.8 bn in 2012, is anticipated to expand exponentially at a CAGR of 32.60% during the period from 2013 to 2019 and … |